There are no Focus articles on SVFC.
There are no Transcripts on SVFC.
Thu, Sep. 4, 12:58 PM
- Intellicell Biosciences (OTCPK:SVFC +5.9%) determines that its financial statements for the quarters ended September 30, 2013 and March 31, 2014 and fiscal year ended December 31, 2013 can no longer be relied upon to be GAAP compliant and will need to be restated.
- It is in the process of re-auditing the statements as well as assessing the effectiveness of its internal controls over financial reporting.
SVFC vs. ETF Alternatives
Regenerative Medicine company using patented technology to manufacuture stromal vascular faction cells containing stem cells for physicians to use under the practice of medicine. Company runs a FDA cGTP cellular lab with SOPs.
Other News & PR